{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:46:02Z","timestamp":1793191562796,"version":"4.5.0"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9020-17","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:13:35Z","timestamp":1507673615000},"page":"115-120","source":"Crossref","is-referenced-by-count":10,"title":["Cryptococcal Pleuritis Presenting with Lymphocyte-predominant and High Levels of Adenosine Deaminase in Pleural Effusions Coincident with Pulmonary Tuberculosis"],"prefix":"10.2169","volume":"57","author":[{"given":"Yoshitomo","family":"Kushima","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Machida","sequence":"additional","affiliation":[{"name":"Nasu Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Umetsu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Chibana","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Takemasa","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Clinical Immunology, Dokkyo Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Young EJ, Hirsh DD, Fainstein V, Williams TW. Pleural effusions due to <i>Cryptococcus neoformans<\/i>: a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis 121: 743-747, 1980."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Epstein R, Cole R, Hunt KK. Pleural effusion secondary to pulmonary cryptococcosis. Chest 61: 296-298, 1972.","DOI":"10.1378\/chest.61.3.296"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Smilack JD, Bellet RE, Talman WT. Cryptococcal pleural effusion. JAMA 232: 639-641, 1975.","DOI":"10.1001\/jama.232.6.639"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Newman TG, Soni A, Acaron S. Pleural cryptococcosis in the acquired immune deficiency syndrome. Chest 91: 459-461, 1987.","DOI":"10.1378\/chest.91.3.459"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Katz AS, Niesenbaum L, Mass B. Pleural effusion as the initial manifestation of disseminated cryptococcosis in acquired immune deficiency syndrome. Diagnosis by pleural biopsy. Chest 96: 440-441, 1989.","DOI":"10.1378\/chest.96.2.440"},{"key":"6","unstructured":"6. Taguchi H, Kotani S, Sugito S, Kobayashi M, Kubonishi I, Miyoshi I. Cryptococcal pleural effusion in an HTLV-I carrier with Waldenstroem&apos;s macroglobulinemia. Acta Med Okayama 46: 45-47, 1992."},{"key":"7","unstructured":"7. Watanabe S, Sakatani M, Kubota K, Yamamoto M, Takahashi Y, Yamamoto S. Primary pulmonary cryptococcosis with pleural effusion, and clinical studies of five cases. Nihon Kyobu Shikkan Gakkai Zasshi (Jpn J Thorac Dis) 33: 1430-1435, 1995 (in Japanese, Abstract in English)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fukuchi M, Mizushima Y, Hori T, Kobayashi M. Cryptococcal pleural effusion in a patient with chronic renal failure receiving long-term corticosteroid therapy for rheumatoid arthritis. Intern Med 37: 534-537, 1998.","DOI":"10.2169\/internalmedicine.37.534"},{"key":"9","unstructured":"9. Matsunaga K, Minakata Y, Yukawa S. Primary pulmonary cryptococcosis with pleural effusion. Nihon Kokyuki Gakkai Zasshi (J Jpn Respir Soc) 36: 708-712, 1998 (in Japanese, Abstract in English)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ramanathan V. Isolated pleural involvement by Cryptococcus in a kidney-pancreas transplant recipient. Nephrol Dial Transplant 17: 321-322, 2002.","DOI":"10.1093\/ndt\/17.2.321"},{"key":"11","unstructured":"11. Nei T, Enomoto T, Sakamoto T, et al. A case of secondary pulmonary cryptococcosis with pleural effusion involving type 1 allergy. Nihon Kokyuki Gakkai Zasshi (J Jpn Respir Soc) 45: 551-555, 2007 (in Japanese, Abstract in English)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Izumikawa K, Zhao Y, Motoshima K, et al. A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment. Med Mycol 46: 595-599, 2008.","DOI":"10.1080\/13693780802074494"},{"key":"13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000216831","volume":"79","author":"Y Yoshino","year":"2009","unstructured":"13. Yoshino Y, Kitazawa T, Tatsuno K, Ota Y, Koike K. Cryptococcal pleuritis containing a high level of adenosine deaminase in a patient with AIDS: a case report. Respiration 79: 153-156, 2009.","journal-title":"Respiration","ISSN":"https:\/\/id.crossref.org\/issn\/0025-7931","issn-type":"print"},{"key":"14","unstructured":"14. Kurahara Y, Tachibana K, Katsura H, et al. A case of cryptococcal empyema successfully treated by debridement by medical thoracoscopy with local anesthesia. Nihon Kokyuki Gakkai Zasshi (J Jpn Respir Soc) 49: 142-147, 2011 (in Japanese, Abstract in English)."},{"key":"15","unstructured":"15. Chen M, Wang X, Yu X, et al. Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review. BMC Infect Dis 15: 385, 2015."},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Gaga M, Papamichalis G, Bakakos P, et al. Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura. Respiration 72: 160-165, 2005.","DOI":"10.1159\/000084047"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Baganha MF, P\u00eago A, Lima MA, Gaspar EV, Cordeiro AR. Serum and pleural adenosine deaminase. Correlation with lymphocytic populations. Chest 97: 605-610, 1990.","DOI":"10.1378\/chest.97.3.605"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Almeida GM, Andrade RM, Bento CAM. The capsular polysaccharides of <i>Cryptococcus neoformans<\/i> activate normal CD4<sup>+<\/sup> T cells in a dominant Th2 pattern. J Immunol 167: 5845-5851, 2001.","DOI":"10.4049\/jimmunol.167.10.5845"},{"key":"19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1843.2010.01723.x","volume":"15","author":"RW Light","year":"2010","unstructured":"19. Light RW. Update on tuberculous pleural effusion. Respirology 15: 451-458, 2010.","journal-title":"Respirology","ISSN":"https:\/\/id.crossref.org\/issn\/1323-7799","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 47: 846-854, 2012.","DOI":"10.1038\/bmt.2011.178"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33: 690-699, 2001.","DOI":"10.1086\/322597"},{"key":"22","unstructured":"22. Dlugovitzky D. In vitro synthesis of interferon-\u03b3, interleukin-4, transforming growth factor-\u03b2 and interleukin-1\u03b2 by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 49: 210-217, 1999."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lienhardt C, Azzurri A, Amedei A, et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 32: 1605-1613, 2002.","DOI":"10.1002\/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kakeya H, Izumikawa K, Yamada K, et al. Three cases of concurrent infection with mycobacterium tuberculosis and <i>Cryptococcus neoformans<\/i>. Intern Med 53: 1685-1692, 2014.","DOI":"10.2169\/internalmedicine.53.1281"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Huang CT, Tsai YJ, Fan JY, Ku SC, Yu CJ. Cryptococcosis and tuberculosis co-infection at a university hospital in Taiwan, 1993-2006. Infection 38: 373-379, 2010.","DOI":"10.1007\/s15010-010-0045-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Panomvana Na Ayudhya D, Thanompuangseree N, Tansuphaswadikul S. Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. Clin Pharmacokinet 43: 725-732, 2004.","DOI":"10.2165\/00003088-200443110-00003"},{"key":"27","unstructured":"27. Dromer F, Mathoulin-P\u00e9lissier S, Launay O, Lortholary O; French Cryptococcosis Study Group. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study. PLoS Med 4: e21, 2007."},{"key":"28","unstructured":"28. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 50: 291-322, 2010."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_9020-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T12:40:31Z","timestamp":1570192831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_9020-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9020-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}